Home » Stocks » PLSE

Pulse Biosciences, Inc. (PLSE)

Stock Price: $12.16 USD 0.03 (0.25%)
Updated Oct 29, 2020 9:30 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 306.58M
Revenue (ttm) n/a
Net Income (ttm) -48.74M
Shares Out 25.21M
EPS (ttm) -2.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 29, 2020
Last Price $12.16
Previous Close $12.13
Change ($) 0.03
Change (%) 0.25%
Day's Open -
Day's Range 12.07 - 12.16
Day's Volume 1,143
52-Week Range 5.11 - 17.77

More Stats

Market Cap 306.58M
Enterprise Value 279.98M
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 25.21M
Float 12.92M
EPS (basic) -2.33
EPS (diluted) -2.32
FCF / Share -1.64
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.36M
Short Ratio 19.28
Short % of Float 18.25%
Beta 1.77
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 7.37
Revenue n/a
Operating Income -49.20M
Net Income -48.74M
Free Cash Flow -35.32M
Net Cash 26.60M
Net Cash / Share 1.06
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -53.29%
ROE -105.74%
ROIC -192.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$16.00*
Low
16.0
Current: $12.16
High
16.0
Target: 16.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue-----
Operating Income-47.95-37.96-25.81-9.59-4.47
Net Income-46.97-37.55-25.57-9.52-2.81
Shares Outstanding20.7517.0814.7511.017.57
Earnings Per Share-2.26-2.20-1.73-0.86-0.37
Operating Cash Flow-34.19-23.90-11.09-8.05-3.32
Capital Expenditures-0.61-0.28-2.55-0.06-0.09
Free Cash Flow-34.79-24.17-13.64-8.12-3.40
Cash & Equivalents25.4059.5838.0716.403.61
Total Debt6.72----
Net Cash / Debt18.6859.5838.0716.403.61
Assets41.9270.6449.8226.3114.33
Liabilities11.184.313.831.020.66
Book Value30.7466.3346.0025.3013.67
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Pulse Biosciences, Inc.
Country United States
Employees 82
CEO Darrin R. Uecker

Stock Information

Ticker Symbol PLSE
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: PLSE
IPO Date May 18, 2016

Description

Pulse Biosciences operates as a novel bioelectric medicine company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.